« Back to Record
Zijlstra, J. J., Follows, G., Casasnovas, R. O., Vermaat, J. J., Kalakonda, N., Choquet, S., Hill, B., Thieblemont, C., Cavallo, F., De la Cruz, F., Kuruvilla, J., Hamad, N., Jäger, U., Caimi, P., Gurion, R., Warzocha, K., Bakhshi, S., Sancho, J. M., Schuster, M., Egyed, M., Offner, F., Vassilakopoulos, T., Samal, P., Ku, M., Xu, J., Corona, K., Chamoun, K., Shah, J., Canales, M., & Maerevoet, M. (2022). The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers (Basel), 14(3), 791. doi:10.3390/cancers14030791
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/340535



